Digital tablecloth to help people with diabetes manage their meals
Tests SMARTCLOTH, a digital tablecloth, in adults with type 1 or type 2 diabetes.
Plain-language title generated from the registry record
Registry title: SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.
Key facts
- Where
- Córdoba, SpainSee the 5 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 70 with type 1 or type 2 diabetes and high blood sugar control values (HbA1c above 7.5), to test a digital tablecloth that helps manage diet.
- Age
- 18 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Type 1 or type 2 diabetes, with the disease present for no more than 15 years.
- Biomarker or test result
- HbA1c greater than 7.5.
Main reasons for not taking part
- Physical or psychological dependence that prevents managing their own diet
- Cancer, autoimmune disease, chronic kidney failure, or a transplant
- Other diseases needing surgery or hospital stays that make follow-up impossible
- Diabetes complications such as eye, kidney, nerve, or heart disease
- A special diet such as for celiac disease or lactose intolerance
Read by machine on 11 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06623708, who can take part
Where in Spain
- Ugc AeropuertoCórdoba, SpainNo longer taking part
- Ugc CentroCórdoba, SpainNo longer taking part
- Ugc FuensantaCórdoba, SpainNo longer taking part
- Ugc La CarlotaCórdoba, SpainNo longer taking part
- Ugc LucanoCórdoba, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Maimónides Biomedical Research Institute of Córdoba
- Trial code
- NCT06623708
- Record updated
- 10 November 2026
- Original description
The objective of this clinical trial is to know the usability and efficacy of SMARTCLOTH for better control and adherence to the dietary patterns recommended to patients with diabetes, both the portion diet system (more common for cases of Diabetes Mellitus type 1 -DM1-), and the plate method (more recommended in cases of Diabetes Mellitus type 2-DM2-). The main questions are:Read full original descriptionShow less
SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.
The objective of this clinical trial is to know the usability and efficacy of SMARTCLOTH for better control and adherence to the dietary patterns recommended to patients with diabetes, both the portion diet system (more common for cases of Diabetes Mellitus type 1 -DM1-), and the plate method (more recommended in cases of Diabetes Mellitus type 2-DM2-). The main questions are:
* Does the use of SMARTCLOTH improve glycemic control in patients with diabetes mellitus? * Do patients with diabetes mellitus find SMARTCLOTH useful in their daily lives?
The researchers will compare changes over 3 months in variables related to glycemic control in two groups, one using SMARTCLOTH (intervention group) and the other following standard recommendations (control group). To do so, participants will have to:
* Use SMARTCLOTH for 3 months or follow the recommendations they receive from their referring health professionals. * Come back after three months for a check-up of the chosen variables. * The experimental group should contact the investigators in case the hardware has any problems.
Exclusion: Oncological or autoimmune disease, chronic renal insufficiency, transplant patients and others that alter the values of the result variables or may constitute a confounding factor; Other diseases that entail surgical interventions or hospital admissions that make it impossible to follow up the study; Patients with complications due to the evolution of the diabetic pathology: retinopathy, nephropathy, polyneuropathy, ischemic heart disease, as well as other micro and macrovascular complications derived from the same and already recorded in the patient; Those subjects subjected to specific dietary regimes such as celiac disease, lactose intolerant, etc; Degree of dependence (physical or psychological) that makes it impossible for them to perform autonomous self-care of the dietary-nutritional regimen.